| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Maribavir | 126.00 | High level resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection. (Sep 2024) | |
| Ganciclovir | 8.50 | High level resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection. (Sep 2024) |